The Regulatory Philosophy and Practice of Emerging Pharmaceutical Technologies Issued by US Food and Drug Administration

Li Xiangyu, Mei Ni, Chen Guiliang

Chinese Pharmaceutical Affairs ›› 2020, Vol. 34 ›› Issue (7) : 836-839.

Chinese Pharmaceutical Affairs ›› 2020, Vol. 34 ›› Issue (7) : 836-839. DOI: 10.16153/j.1002-7777.2020.07.017
Foreign Pharmacy

The Regulatory Philosophy and Practice of Emerging Pharmaceutical Technologies Issued by US Food and Drug Administration

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2020, 34(7): 836-839 https://doi.org/10.16153/j.1002-7777.2020.07.017

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail

Sections
Recommended

/